EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Reduction-Responsive Nanoparticles Self-Assembled from Sericin-ss-Doxorubicin Conjugate for Hydrophobic IR780 Delivery with Integration of Antitumor Chemo-Phototherapy

Lulu Zhang, Haiyang Liu, Jin Ren, Junyi Shao, Yanrong Cao, Shuangshuang Wang, Changchun Peng, Shengwen Shao, Haixia Ge iD, Jingmou Yu iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s553474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Lulu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Huzhou Key Laboratory of Medical and Environmental Applications Technologies, School of Life Sciences, Huzhou University, Huzhou, People's Republic o…. Hauptthemen laut MEDLINE: Doxorubicin, Indoles, Sericins, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinIndolesSericinsNanoparticlesAntineoplastic AgentsAnimalsCell Line, TumorMiceDrug LiberationHydrophobic and Hydrophilic InteractionsReactive Oxygen SpeciesFemaleSpheroids, CellularDrug CarriersHumansCell SurvivalPhotochemotherapyDrug Delivery Systems

Stichwörter der Autor:innen

IR780chemo-phototherapydoxorubicinpolymeric nanoparticlessericin

Substanzen

DoxorubicinIndolesSericins2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dime…Reactive Oxygen SpeciesAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Huzhou Key Laboratory of Medical and Environmental Applications Technologies, School of Life Sciences, Huzhou University, Huzhou, People's Republic of China.
  • Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang, 332005, People's Republic of China.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd., Yichun, 332000, People's Republic of China.

ORCID-Profile: Haixia Ge, Jingmou Yu

Zitieren

APA

Zhang, L., Liu, H., Ren, J., Shao, J., Cao, Y., Wang, S., Peng, C., Shao, S., Ge, H., & Yu, J. (2025). Reduction-Responsive Nanoparticles Self-Assembled from Sericin-ss-Doxorubicin Conjugate for Hydrophobic IR780 Delivery with Integration of Antitumor Chemo-Phototherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s553474

Vancouver

Zhang L, Liu H, Ren J, Shao J, Cao Y, Wang S, et al. Reduction-Responsive Nanoparticles Self-Assembled from Sericin-ss-Doxorubicin Conjugate for Hydrophobic IR780 Delivery with Integration of Antitumor Chemo-Phototherapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s553474

BibTeX
@article{Zhang2025,
  author = {Zhang, Lulu and Liu, Haiyang and Ren, Jin and Shao, Junyi and Cao, Yanrong and Wang, Shuangshuang and Peng, Changchun and Shao, Shengwen and Ge, Haixia and Yu, Jingmou},
  title = {Reduction-Responsive Nanoparticles Self-Assembled from Sericin-ss-Doxorubicin Conjugate for Hydrophobic IR780 Delivery with Integration of Antitumor Chemo-Phototherapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s553474}
}
Kostenlos starten →